Recombinant Anti-IL-18 (Clone 125-2H)
Applications | ELISA, IF, IP |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-IL-18 (Clone 125-2H)
Applications | ELISA, IF, IP |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-IL-18 (Clone 125-2H)
Applications | ELISA, IF, IP |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-TNF alpha (Clone cA2 (Infliximab))
Applications | ELISA, FC |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-TNF alpha (Clone cA2 (Infliximab))
Applications | ELISA, FC |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-TNF alpha (Clone cA2 (Infliximab))
Applications | ELISA, FC |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CALR (Clone SAIC-16D-6B9)
Applications | ELISA, WB |
Reactivities | Human |
Conjugation | Unconjugated |
USD 523.00
2 Weeks
Recombinant Anti-TNF alpha (Clone CDP 571 (Humicade))
Applications | ELISA |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. |
USD 523.00
2 Weeks
Recombinant Anti-TNF alpha (Clone CDP 571 (Humicade))
Applications | ELISA |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. |
USD 523.00
2 Weeks
Recombinant Anti-TNF alpha (Clone CDP 571 (Humicade))
Applications | ELISA |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-TNF alpha (Clone D2E7 (Adalimumab))
Applications | ELISA, IF, IHC |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. |
Recombinant Anti-TNF alpha (Clone D2E7 (Adalimumab))
Applications | ELISA, IF, IHC |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
USD 523.00
2 Weeks
Recombinant Anti-TNF alpha (Clone D2E7 (Adalimumab))
Applications | ELISA, IF, IHC |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-IL-6 receptor (Clone rhPM-1 (Tocilizumab))
Applications | ELISA |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. |
Recombinant Anti-IL-6 receptor (Clone rhPM-1 (Tocilizumab))
Applications | ELISA |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD74 (Clone LN-2)
Applications | ELISA, FC, IF, IHC, IP, WB |
Reactivities | Human, Mouse, Rat |
Conjugation | Unconjugated |
Recombinant Anti-CD74 (Clone LN-2)
Applications | ELISA, FC, IF, IHC, IP, WB |
Reactivities | Human, Mouse, Rat |
Conjugation | Unconjugated |
Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. |